Grey Matters Health Launches First U.S. Dedicated PET Neuroimaging Clinic — Grey Matters Health Inc.

Event summary

Grey Matters Health appoints Dr. Jayson A. Lord, MD as Medical Director of its first U.S. PET neuroimaging clinic in Davie, Florida, set to open in September 2026.
The clinic will use the FDA-cleared CareMiBrain™ system, offering seated scan design and 25% less radiation exposure compared to traditional PET/CT scanners.
The facility aims to address the growing demand for Alzheimer’s Disease diagnostics, supported by Medicare, Medicaid, and private insurance coverage.
Grey Matters Health plans to expand its NovaScan Neuroimaging Clinics™ nationwide.

The big picture

Grey Matters Health is positioning itself to capitalize on the growing market for Alzheimer’s Disease diagnostics, driven by the recent FDA approvals of monoclonal antibody treatments like Leqembi and Kisunla. The company’s focus on dedicated PET neuroimaging clinics addresses a critical gap in the current healthcare infrastructure, where existing PET/CT scanners are primarily used for cancer and cardiac imaging. By introducing the CareMiBrain™ system, Grey Matters Health aims to streamline the diagnostic process, reduce radiation exposure, and improve patient access to timely brain scans.

What we're watching

Market Expansion: Whether Grey Matters Health can successfully scale its NovaScan Neuroimaging Clinics™ across the U.S. to meet the rising demand for Alzheimer’s diagnostics.
Regulatory Compliance: How the FDA-cleared CareMiBrain™ system will perform in real-world settings and whether it can maintain its regulatory approval status.
Competitive Dynamics: The pace at which competitors like Eisai, Biogen, and Eli Lilly may respond with their own diagnostic and treatment innovations for neurodegenerative diseases.